EUVIMEDEUVIMED entdecken
Crossref

Educational Attainment and Drug Firm Innovation

Xiaoming Liu, Shanshan Zhou, Zhaohui Zhang

Journal of Applied Business and Economics · 29.07.2026 · 28 (4)

DOI: 10.33423/wxxs2c39 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Business and Economics, online erschienen am 29.07.2026. Verfasst von Xiaoming Liu und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Few researchers have distinguished the marginal effects of educational attainment within the tertiary level on firm-level innovation. We examine the impact of academic degrees on firms’ innovation activities in the talent-demanding drug industry in China. We find that the educational attainment factors, along with R&D spending, tend to dominate other types of firm capital in innovation output. More importantly, our findings on innovation efficiency could reconcile some conflicting views for large and small firms in the literature. Further, small-molecule drugs have received far more patents than biologics, but the latter have had a similar number of drug pipelines.

Zitieren

APA

Liu, X., Zhou, S., & Zhang, Z. (2026). Educational Attainment and Drug Firm Innovation. Journal of Applied Business and Economics, 28(4). https://doi.org/10.33423/wxxs2c39

Vancouver

Liu X, Zhou S, Zhang Z. Educational Attainment and Drug Firm Innovation. Journal of Applied Business and Economics. 2026;28(4). doi:10.33423/wxxs2c39

BibTeX
@article{Liu2026,
  author = {Liu, Xiaoming and Zhou, Shanshan and Zhang, Zhaohui},
  title = {Educational Attainment and Drug Firm Innovation},
  journal = {Journal of Applied Business and Economics},
  year = {2026},
  volume = {28},
  number = {4},
  doi = {10.33423/wxxs2c39}
}
Kostenlos starten →